Evidence map›Paper›PMID 32458086›Full record

ReviewPflugers Archiv : European journal of physiology2020

Rare CACNA1A mutations leading to congenital ataxia.

Mercè Izquierdo-Serra, José M Fernández-Fernández, Mercedes Serrano

Abstract readReview
PubMed Publisher
In one paragraph

Review in Pflugers Archiv : European journal of physiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Phenotypic variability in cases with CACNA1A mutation.European journal of pediatrics · 2025
    Article
  2. Article
  3. Article
  4. A Review of theDiseases (Basel, Switzerland) · 2024
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Complex effects on CaScientific reports · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Voltage-Gated CaFrontiers in synaptic neuroscience · 2021
    Review
  16. Developing a pathway to clinical trials forTherapeutic advances in rare disease
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Mercè Izquierdo-SerraLaboratori de Fisiologia Molecular, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, C/ Dr. Aiguader, 88, 08003, Barcelona, Spain.
José M Fernández-FernándezLaboratori de Fisiologia Molecular, Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, C/ Dr. Aiguader, 88, 08003, Barcelona, Spain. jmanuel.fernandez@upf.edu.ORCID 0000-0003-2330-8449
Mercedes SerranoNeuropediatric Department, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, 08950, Barcelona, Spain. mserrano@sjdhospitalbarcelona.org.ORCID 0000-0002-2056-2428
Universitat Pompeu Fabra · ESHospital Sant Joan de Déu Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human mutations in the CACNA1A gene that encodes the pore-forming α

Indexed as

Amino Acid SequenceAnimalsAtaxiaCalcium ChannelsHumansMutationCalcium ChannelsCACNA1A geneCaV2.1 (P/Q-type) voltage-dependent calcium channelCerebellar atrophyCongenital ataxiaEarly-onset cerebellar signsPermanent ataxia

Identifiers

PMID32458086
OpenAlexW3032214169

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.